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Abstract
To study the effects of modifications to the extracellular matrix (ECM) on cell viability in
retinal pigment epithelial (RPE) cells. Age-related macular degeneration (AMD) is one of the
most prevalent causes of vision loss across industrialized nations, and currently there is no
effective treatment to stop the progression of the disease. AMD can be further subdivided into
wet AMD or dry AMD with about ninety percent of patients receiving the latter diagnosis. In the
course of this disease, RPE cells die, leading to loss of central vision. As individuals age,
proteins in the RPE extracellular matrix undergo glycation and nitration which diminishes the
ability of RPE cells to attach to the basement membrane. This phenomenon contributes to the
loss of photoreceptors in the central, macular region which leads to loss of central vision.
Glycation and nitration are important ECM chemical modifications that are commonly seen in
postmortem individuals and patients suffering from chronic retinal inflammation, respectively.
Knowledge of the effect of chemically modified ECM on retinal pigment epithelial cells may
allow for the development of targeted treatments. Previous studies have shown diminished cell
viability for RPE cells on both modified matrices. This research consisted of using the ARPE-19
cell line and ECM chemical modifications as a model for what occurs in the human eye with age.
The current data was collected for biological replicates on both modified matrices, and both did
not show significant decrease in cell proliferation. This research provides background on
progression of retinal diseases by examining the effects of nitrite and glycoaldehyde modified
ECMs on RPE cell behavior as a potential model for targeted AMD therapeutics.

Project Description
Background

Age-related macular degeneration (AMD) is one of the leading causes of vision loss
across industrialized nations (Jager, Mieler, & Miller, 2008). There are both genetic and
environmental factors involved in the development of AMD, with race playing an important role
in its development (McKay & Schwartz, 2016). AMD most commonly occurs in Caucasians, less
in African Americans, and has a midway occurrence among Asians and Hispanics (McKay &
Schwartz, 2016).
AMD is known to cause deterioration of the retina, with major effects on the retinal
pigment epithelium (RPE) and choroid. AMD is further subdivided into dry AMD and wet
AMD. Dry AMD is most commonly characterized by the drusen, or debris, deposits it leaves in
the center of the retina (Glenn et al., 2019). Wet AMD occurs when blood vessels below the
macula region leak (Glenn, Mahaffy, Wu, Smith, Nagai, Simpson, Boulton, & Stitt, 2019).
Provided its location as the outermost layer of the retina, the RPE is critical in many retinal
processes such as nutrient transport, light absorption, and formation of the blood-retina barrier
(Dunn, Aotaki-Keen, Putkey & Hielmeland, 1996). Detection of AMD is commonly due to
accumulation of drusen found between the RPE and Bruch’s membrane (Dunn et al., 1996).
Literature hypothesizes that aging of the Bruch membrane and the development of AMD may be
the result of chemical modifications of extracellular matrix proteins (ECM) (Wang, Paik, Priore,
Scholar, & Gaillard, 2005). The ECM is important in many structural and biochemical functions
within cells, therefore studying modifications commonly observed in individuals will allow for
further understanding of the pathway leading to AMD. Modification by glycation is frequently
observed in the Bruch membrane and drusen of postmortem individuals (Glenn et al., 2019). The
role of nitric oxide in AMD progression is important due to its influence as a biological marker
and its association with chronic inflammation (Wang et al., 2005). Therefore, nitration is another

chemical modification that has been widely associated with AMD.

Statement of Significance and Impact
Both glycation and a nitration are chemical modifications that occur in the RPE ECM as
individuals age, and this leads to loss of central vision. Therefore, the aim of this research is to
examine the effects of nitrite and glycoaldehyde modified ECM’s on RPE cell behavior as a
potential model for targeted AMD therapeutics.

Methods
ARPE-19 is a human retinal cell line purchased from American Type Culture Collection.
The ARPE-19 cell line was thawed and maintained in Dulbecco’s Modified Eagle Media
(DMEM) supplemented with 10% Fetal Bovine Serum, 1.1% L-glutamine, and 1.1% penicillinstreptomycin.
When cells became confluent, they were plated at a density of 50,000 cells per milliliter
(cells/mL) per well of a 12-well plate. Media changes were conducted every three to four days
for six to eight weeks until sufficient ECM was formed. Cells were detached from the wells with
ammonium hydroxide and the remaining ECM was subject to either nitration or glycation. For
the nitration experiments, ECMs were modified using 200mM sodium nitrite in pH 5 acetate
buffer and incubated for one week. The control ECMs were incubated in pH 5 acetate buffer. For
the glycation experiments, ECMs were modified using 50mM glycoaldehyde in pH 7.4 PBS and
incubated for twelve hours. The control ECMs were incubated in a 1X phosphate-buffered saline
(PBS) solution.
After respective incubations, cells were washed with PBS, dried, and frozen at -80°C for

up to two weeks. After thawing the ECM that was previously frozen, 50,000 cells/mL of ARPE19 cells were seeded onto the ECM and incubated for 24 hours (+/- 2 hours) to allow for cell
attachment. Cells were washed with PBS and layered with a 0.5 milligram per milliliter 3- (4,5dimethylthiazol-2-yl)-2,5-diphenultetrazolium bromide (MTT) working solution. After 90
minutes, the MTT solution was aspirated and samples were dissolved in dimethyl sulfoxide. The
absorbance of the samples in the 12-well plate was measured at 560 nanometers using the
BioTek Synergy plate reader. Raw data was analyzed using a t-test assuming equal variance for
comparison between modified and unmodified ECM.
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Figure 1. Relative cell proliferation after modification by glycation (A&B) or
nitration (C&D).

Discusion & Conclusion
Data above demonstrates no statistical difference in relative cell proliferation between
cells exposed to a modified matrix by either glycation (A&B) or nitration (C&D), and an
unmodified matrix. When newly seeded cells are exposed to a modified matrix, a decrease in cell
proliferation is expected compared to the control. The MTT assay used is a colorimetric assay
that assesses the metabolic activity of the ARPE-19 cells after exposure to modified or
unmodified ECM. Relative proliferation is the increase in number of ARPE-19 cells due to cell
growth and division. If there are more metabolically active cells present, then a higher
absorbance reading will be measured by the plate reader, and this denotes an overall higher cell
proliferation. Our controls, which are the cells exposed to unmodified matrix were hypothesized
to exhibit a cell proliferation that is higher compared to cells exposed to modified matrix. In the
human eye, modifications to RPE ECM are theorized to cause a loss of central vision. Therefore,
mimicking the effect in lab may allow for understanding of the cell death mechanism found in
the human eye.
Previous studies have shown diminished viability for RPE cells on both modified
matrices (Wang et al., 2005). Possible explanations for our wider variation in results include:
matrix modification, proliferation assay, and protocol. Prior to modification of RPE ECM, a
quantitative assay will be developed to assure that the chemical reagents used are in fact
modifying the ECM. Based on conflicting results of later experimentation with the MTT assay
solution used, a new assay will be used to quantify the relative cell proliferation. The protocol
used for experimentation involved multiple incubation periods that can be examined and altered
successively to measure for any differences in cell proliferation. This research demonstrates the

importance of biological replicates when determining potential therapeutic benefit of a
laboratory induced model system.
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